Invesco Ltd.

Position in IRON — Disc Medicine, Inc.

CIK 914208 Atlanta, GA

Position in IRON

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,076,047

+$1,117,056 QoQ

Shares Held

42,057

+37.3% QoQ

Ownership

0.110%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#79

of 216 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 98% None 2%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. IRON ranks #99 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,076,047	42,057	+37.3%	Shares	Defined	2026-08-14
2026-03-31	$1,958,991	30,638	-49.8%	Shares	Defined	2026-05-12
2025-12-31	$4,849,565	61,070	+184.8%	Shares	Defined	2026-02-19
2025-09-30	$1,416,950	21,443	+27.5%	Shares	Defined	2025-11-13
2025-06-30	$890,626	16,817	+21.6%	Shares	Defined	2025-08-13
2025-03-31	$686,719	13,834	+27.1%	Shares	Defined	2025-05-12
2024-12-31	$689,854	10,881	+93.3%	Shares	Defined	2025-02-13
2024-09-30	$276,557	5,628	-0.2%	Shares	Defined	2024-11-12
2024-06-30	$254,103	5,638	-92.1%	Shares	Defined	2024-08-13
2024-03-31	$4,447,542	71,435	-37.4%	Shares	Defined	2024-05-14
2023-12-31	$6,588,566	114,068	-29.2%	Shares	Defined	2024-02-13
2023-09-30	$7,573,785	161,213	+45.7%	Shares	Defined	2023-11-13
2023-06-30	$4,912,060	110,632	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.